October 2012 FDA Recall Drug by Hospira Inc.
D-106-2013 - Presence of Particulates; may contain glass particles

This Class II drug recall was voluntarily initiated by Hospira Inc. on October 25, 2012 for the product Drug. The FDA reported the reason for recall as presence of particulates; may contain glass particles. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-106-2013

Reason for Recall
Presence of Particulates; may contain glass particles
Initiated
10-25-2012
Reported
01-09-2013
Quantity
361,600/1-mL ampules

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
63589
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Hospira Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-15-2014
Product Description About Product Description
Full technical description of the product.
Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01

Batch or Lot Expiration Information

Lot# Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013